From December 28th to 30th, the 5th Brain Science Frontier and Industry Conference and 2025 Shenzhen Brain Computer Interface Expo (hereinafter referred to as "2025 Shenzhen Brain Expo") will be held at Guangming Science City. This is the fifth consecutive year that the Shenzhen Hong Kong Institute of Brain Science Innovation and the Shenzhen Brain Science Society have jointly hosted this academic dialogue and industry conference. At the end of the year, the conference brought research progress and the latest achievements from multiple institutions and enterprises in the field of neuroscience and brain computer interface from all over the country, making the layout of Shenzhen's neuroscience industry, academia, and research clearer.
Building a platform, diverting active water, nurturing ecology, and constructing a brain science innovation rainforest in Shenzhen
Looking back at the timeline of the end of 2025, neuroscience and brain computer interface technology are at a critical point of technological transformation.
In the wave of global technological revolution and industrial transformation, neuroscience and brain computer interface technology have become strategic high points for countries to compete in layout. In 2025, seven ministries and commissions of the country will release the "Implementation Opinions on Promoting the Innovative Development of the Brain Computer Interface Industry", and the "15th Five Year Plan" proposal and the Central Economic Work Conference will clarify the forward-looking layout of future industries, placing brain computer interfaces in an important position to cultivate new quality productivity and seize the high ground of future competition.
As early as the 13th Five Year Plan period, Shenzhen city proactively planned and laid out a roadmap for the development of brain science throughout the city. In 2019, Shenzhen supported the construction of the Shenzhen Hong Kong Brain Science Innovation Research Institute; In 2022, Guangming District of Shenzhen issued the first district level special policy in the field of neuroscience in China, providing up to 10 million yuan in funding for major scientific research projects and offering full cycle support such as venues, talents, and clinical verification to start-up enterprises.
Capital flows closely following policies. At this year's 2025 Shenzhen Brain Expo, two brain science industry funds, "Shenzhen Zhongjin Brain Science and Brain like Intelligent Industry Private Equity Investment Fund" and "Shenzhen Blue Ocean Intelligent Brain Seed Fund", were signed with a total scale of 1.16 billion yuan. Two funds provide enterprises with a complete technology and financial support system covering early "sowing" to growth "irrigation", bringing "super vitality" to the neuroscience and brain computer interface industry.
Previously, Shenzhen has continuously invested in supporting basic research and industrialization of neuroscience through multiple channels such as municipal and municipal finance, social capital, etc. Under the continuous release of real policy dividends, currently, only Guangming Science City has gathered over 80 brain science related enterprises with a total valuation of over 10 billion yuan, including multiple large-scale enterprises and 14 national high-tech enterprises, forming a development pattern of "leading and small and medium-sized cooperation", and initially forming a complete chain of "basic research - technological breakthroughs - product transformation - market application".
Behind this "industry university research application" chain is a key "hub": the first national brain science and technology industry innovation center located in Guangming Science City. Focusing on the key pain points and common needs of industrial transformation in the fields of neuroscience and neuromorphic intelligence, the Brain Innovation Center has established 11 enterprise shared technology platforms, which not only enable the rapid low-cost verification of cutting-edge neuroscience technologies, but also enable capital to link to enterprises more quickly and quickly turn research results into products.
Since 2021, the Shenzhen Hong Kong Institute of Brain Science Innovation and the Shenzhen Brain Science Society have continued to hold conferences on scientific frontiers and industries, providing a platform for enterprises, academic resources, and capital to further integrate industries and innovate. This conference has taken a crucial step forward - the "Guangdong Hong Kong Macao Greater Bay Area Brain Science and Central Nervous Disease AI Innovation Alliance" has been officially established. The alliance is led by the Green Leaf Life Science Group and the Brain Innovation Center, and collaborates with nearly 20 top hospitals, universities, research institutions, and legal service organizations to focus on three major industry directions: drug innovation for neurological diseases, brain computer interfaces, and AI brain health and medical care. It is committed to building a full chain innovation platform in the fields of neuroscience and central nervous system diseases.
